Advarra Blog

Featured Post

The Next Generation of CIRBI, the Technology Powering Advarra’s IRB

For more than 40 years, Advarra’s institutional review board (IRB) has been built on a simple commitment: quality, clarity, and care in every review. That commitment hasn’t changed, and it never will. What does change—what has to change—is how we deliver on it. The research community moves faster every year, and the sponsors, sites, and CROs we serve deserve oversight that is as thoughtful and rigorous as it has always been, paired with the speed, expertise, and transparency that modern research demands.

Hands typing on a computer

How Amendment Intelligence Helps Reduce Avoidable Protocol Revisions

Clinical development teams can use operational and institutional review board (IRB) data to identify protocol-design…

Read more

Improving Clinical Trial Site Collaboration with Connected Study Startup Workflows 

Clinical trial study startup requires constant coordination across sponsors, contract research organizations (CROs), research sites,…

Read more

The Next Generation of CIRBI, the Technology Powering Advarra’s IRB

A note from Lauri Carlile, Chief Research Services Officer: For more than 40 years, Advarra’s…

Read more
Typing, medical research and man with laptop, scientist and info for biotechnology, website and lab. Healthcare, researcher and person with tech for clinical data, analysis and study for science.

21 CFR Part 11 and Good Clinical Practice Requirements Explained 

Clinical research increasingly depends on electronic systems to support core trial documentation, data handling, and…

Read more

Q&A with Advarra’s Client Services Team Lead Kyle Naylor 

Kyle Naylor didn’t set out to work in the IRB world—but once he found it, he never…

Read more

A Practical Checklist for Building Confidence in Site Selection

How operational insight, performance data, and patient access signals can strengthen clinical trial site decisions …

Read more

Sponsor’s Guide to IRB Approval (Part VI): After IRB Approval: Compliance, Multi-Site Oversight, and Turning Review into a Strategic Advantage 

IRB approval is a critical milestone in clinical research, but it isn’t the end of the oversight…

Read more

Do DSMBs Need AI Expertise?

Rethinking oversight as clinical trials become more data-driven and algorithm-informed  As artificial intelligence (AI) becomes…

Read more

What Protocol Amendments Reveal About Trial Design

Key takeaways from ‘The Operational Realities of Protocol Amendments’ panel discussion at the Advarra Innovation…

Read more

Q&A with Advarra’s Manager of Ongoing Review MaryJo Carter 

MaryJo Carter has spent more than nine years at Advarra, growing alongside the organization and helping shape…

Read more

Sponsor’s Guide to IRB Approval (Part V): How to Speed Up IRB Approvals 

Institutional review board (IRB) approval is a critical milestone in clinical research, but it can…

Read more
Typing, medical research and man with laptop, scientist and info for biotechnology, website and lab. Healthcare, researcher and person with tech for clinical data, analysis and study for science.

Data Safety Monitoring Boards (DSMBs) in the Era of AI and Adaptive Clinical Trials

Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials  Clinical trials are…

Read more

Looking for More?

To register for upcoming webinars and see where we’ll be next, go to the Events page.

Want to see the latest news and updates about Advarra? You can find them in the Newsroom.

Are You Ready To Bring People Together for Better, Faster Trial Outcomes?

Subscribe to our monthly email

Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.

Login
Scroll to Top